Skip to main content

Xunrong Luo

Boyce Haller Distinguished Professor in Nephrology
Medicine, Nephrology
DUMC Box 103015, Durham, NC 27710
2 Genome Court, Durham, NC 27710

Selected Grants


Advanced Immunobiology Traning Program for Surgeons

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029

U2C/TL1 NC KUH TRIO Administrative Core

ResearchPreceptor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

Medical Scientist Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027

Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors

ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027

Promoting T cell recovery after radiation injury with long-acting interleukin 7

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027

Advanced Immunobiology Traning Program for Surgeons

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029

U2C/TL1 NC KUH TRIO Administrative Core

ResearchPreceptor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

Medical Scientist Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027

Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors

ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027

Promoting T cell recovery after radiation injury with long-acting interleukin 7

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027

Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity

ResearchPrincipal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2022 - 2027

Neonatal porcine islet xenografts for the treatment of type 1 diabetes

ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2014 - 2025

Mathematical modeling for optimal control of BK virus infection in kidney transplant recipients

ResearchCollaborator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2025

Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2023

Duke Training Grant in Nephrology

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1995 - 2023

TAM-Kinases in Transplant

ResearchPrincipal Investigator · Awarded by Northwestern University · 2018 - 2022

Medical Scientist Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1997 - 2022

Modeling concurrent cytomegalovirus infection and transplantation tolerance

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2022

Donor apoptotic cell infusion for tolerance to monkey kidney allografts

ResearchCo Investigator · Awarded by The Board of Regents of the University of Wisconsin System · 2019 - 2021

Tolerance for Xenogeneic Islet Cell Transplantation in Non-human Primates

ResearchPrincipal Investigator · Awarded by Northwestern University · 2018 - 2020

Pig-to-Monkey Islet Xenotransplantation

ResearchPrincipal Investigator · Awarded by University of Minnesota · 2018 - 2020

Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy

ResearchPrincipal Investigator · Awarded by Regents of the University of Michigan · 2018 - 2020

LNFPIII and GAS6 Signaling Nanoparticles for Tolerance Delivery

ResearchPrincipal Investigator · Awarded by Juvenile Diabetes Research Foundation · 2018 - 2019

External Relationships


  • Diabetes-Free, Inc
  • Houston Methodist Hospital
  • Juvenile Diabetes Research Foundation

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.